Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$2.39 -0.09 (-3.63%)
As of: Nov 12, 2026 · 9:30 AM EST

Galmed Pharmaceuticals (EOCN) Return on Invested Capital [ROIC] (2016 - 2018)

Updated

Galmed Pharmaceuticals' Return on Invested Capital [ROIC] was 13.96% in FY2024, down 38.13 percentage points from 52.08% in FY2023.

Analysis

Galmed Pharmaceuticals (EOCN) Return on Invested Capital [ROIC] (2016 - 2018) Analysis & Trends

From FY2016 onward, Galmed Pharmaceuticals has reported Return on Invested Capital [ROIC] for 4 years.

  • Per Business Quant data, Return on Invested Capital [ROIC] in earlier years was 52.08% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Galmed Pharmaceuticals 2.06 Mn -38.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -18.03%
Sep 30, 2018 -21.49%
Jun 30, 2018 -34.31%
Jun 30, 2017 119.65%
Dec 31, 2016 119.61%
Sep 30, 2016 98.89%
Jun 30, 2016 85.45%
API Access

Galmed Pharmaceuticals Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=EOCN&period=max&api_key=YOUR_API_KEY